Total Funding
78
83
Total FundingGrant raised
Growth Score
-15 pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
159007
Intervacc is a biotechnology company that develops vaccines based on recombinant proteins for animal health.
Carl-Johan Dalsgaard: Chief Executive Officer and Group CEOPast Role: Vicore Pharma, Chief Executive Officer
Björn Sjöstrand: Chairman Of The Supervisory Board
About the Company
Intervacc develops vaccines based on recombinant proteins for use in animal health care. They focus on diagnostics in the animal health market and provide bacteriological and mycological analyzes.
